199 related articles for article (PubMed ID: 23088865)
1. Methylphenidate effects on blood serotonin and melatonin levels may help to synchronise biological rhythms in children with ADHD.
Molina-Carballo A; Naranjo-Gómez A; Uberos J; Justicia-Martínez F; Ruiz-Ramos MJ; Cubero-Millán I; Contreras-Chova F; Augustin-Morales MD; Khaldy-Belkadi H; Muñoz-Hoyos A
J Psychiatr Res; 2013 Mar; 47(3):377-83. PubMed ID: 23088865
[TBL] [Abstract][Full Text] [Related]
2. Methylphenidate ameliorates depressive comorbidity in ADHD children without any modification on differences in serum melatonin concentration between ADHD subtypes.
Cubero-Millán I; Molina-Carballo A; Machado-Casas I; Fernández-López L; Martínez-Serrano S; Tortosa-Pinto P; Ruiz-López A; Luna-del-Castillo JD; Uberos J; Muñoz-Hoyos A
Int J Mol Sci; 2014 Sep; 15(9):17115-29. PubMed ID: 25257531
[TBL] [Abstract][Full Text] [Related]
3. BDNF concentrations and daily fluctuations differ among ADHD children and respond differently to methylphenidate with no relationship with depressive symptomatology.
Cubero-Millán I; Ruiz-Ramos MJ; Molina-Carballo A; Martínez-Serrano S; Fernández-López L; Machado-Casas I; Tortosa-Pinto P; Ruiz-López A; Luna-Del-Castillo JD; Uberos J; Muñoz-Hoyos A
Psychopharmacology (Berl); 2017 Jan; 234(2):267-279. PubMed ID: 27807606
[TBL] [Abstract][Full Text] [Related]
4. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
Chou WJ; Chou MC; Tzang RF; Hsu YC; Gau SS; Chen SJ; Wu YY; Huang YF; Liang HY; Cheng H
Psychiatry Clin Neurosci; 2009 Apr; 63(2):167-75. PubMed ID: 19335386
[TBL] [Abstract][Full Text] [Related]
5. Attention-deficit/hyperactivity disorder and comorbid subsyndromal depression: what is the impact of methylphenidate on mood?
Golubchik P; Kodesh A; Weizman A
Clin Neuropharmacol; 2013; 36(5):141-5. PubMed ID: 24045603
[TBL] [Abstract][Full Text] [Related]
6. Differential responses of two related neurosteroids to methylphenidate based on ADHD subtype and the presence of depressive symptomatology.
Molina-Carballo A; Justicia-Martínez F; Moreno-Madrid F; Cubero-Millán I; Machado-Casas I; Moreno-García L; León J; Luna-Del-Castillo JD; Uberos J; Muñoz-Hoyos A
Psychopharmacology (Berl); 2014 Sep; 231(17):3635-45. PubMed ID: 24599397
[TBL] [Abstract][Full Text] [Related]
7. Changes in plasma Brain-derived neurotrophic factor (BDNF) levels induced by methylphenidate in children with Attention deficit-hyperactivity disorder (ADHD).
Amiri A; Torabi Parizi G; Kousha M; Saadat F; Modabbernia MJ; Najafi K; Atrkar Roushan Z
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():20-4. PubMed ID: 23933054
[TBL] [Abstract][Full Text] [Related]
8. Ginkgo biloba for attention-deficit/hyperactivity disorder in children and adolescents: a double blind, randomized controlled trial.
Salehi B; Imani R; Mohammadi MR; Fallah J; Mohammadi M; Ghanizadeh A; Tasviechi AA; Vossoughi A; Rezazadeh SA; Akhondzadeh S
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):76-80. PubMed ID: 19815048
[TBL] [Abstract][Full Text] [Related]
9. Impact of long-term treatment of methylphenidate on height and weight of school age children with ADHD.
Zhang H; Du M; Zhuang S
Neuropediatrics; 2010 Aug; 41(2):55-9. PubMed ID: 20799150
[TBL] [Abstract][Full Text] [Related]
10. Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: results from a Taiwanese sample.
Yang P; Hsu HY; Chiou SS; Chao MC
Aust N Z J Psychiatry; 2007 Dec; 41(12):998-1004. PubMed ID: 17999272
[TBL] [Abstract][Full Text] [Related]
11. The influence of methylphenidate on the power spectrum of ADHD children - an MEG study.
Wienbruch C; Paul I; Bauer S; Kivelitz H
BMC Psychiatry; 2005 Jul; 5():29. PubMed ID: 16042816
[TBL] [Abstract][Full Text] [Related]
12. Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder.
Polanczyk G; Zeni C; Genro JP; Guimarães AP; Roman T; Hutz MH; Rohde LA
Arch Gen Psychiatry; 2007 Feb; 64(2):218-24. PubMed ID: 17283289
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of methylphenidate in treating ADHD symptoms in children and adolescents with uncontrolled seizures: a Brazilian sample study and literature review.
Koneski JA; Casella EB; Agertt F; Ferreira MG
Epilepsy Behav; 2011 Jul; 21(3):228-32. PubMed ID: 21524941
[TBL] [Abstract][Full Text] [Related]
15. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
[TBL] [Abstract][Full Text] [Related]
16. Effect of methylphenidate on height and weight in Korean children and adolescents with attention-deficit/hyperactivity disorder: a retrospective chart review.
Kim HW; Kim SO; Shon S; Lee JS; Lee HJ; Choi JH
J Child Adolesc Psychopharmacol; 2014 Oct; 24(8):448-53. PubMed ID: 25285915
[TBL] [Abstract][Full Text] [Related]
17. Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures.
Posey DJ; Aman MG; McCracken JT; Scahill L; Tierney E; Arnold LE; Vitiello B; Chuang SZ; Davies M; Ramadan Y; Witwer AN; Swiezy NB; Cronin P; Shah B; Carroll DH; Young C; Wheeler C; McDougle CJ
Biol Psychiatry; 2007 Feb; 61(4):538-44. PubMed ID: 17276750
[TBL] [Abstract][Full Text] [Related]
18. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
[TBL] [Abstract][Full Text] [Related]
19. The adolescent outcome of children with attention deficit hyperactivity disorder treated with methylphenidate or methylphenidate combined with multimodal behaviour therapy: results of a naturalistic follow-up study.
van der Oord S; Prins PJ; Oosterlaan J; Emmelkamp PM
Clin Psychol Psychother; 2012; 19(3):270-8. PubMed ID: 21404369
[TBL] [Abstract][Full Text] [Related]
20. Body mass index of children with attention-deficit/hyperactivity disorder.
Dubnov-Raz G; Perry A; Berger I
J Child Neurol; 2011 Mar; 26(3):302-8. PubMed ID: 20929910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
